fbpx
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

2021 Clinical Innovation Grant Round Recipients

Wesley Medical Research is excited to announce the recipients of our 2021 Clinical Innovation Grant Round. With the support of generous philanthropists and donors including a significant contribution from UnitingCare Qld, Wesley Medical Research had over $1.02 million available for project grants to support research across the four UnitingCare Hospitals. Congratulations go to:
This project will test the feasibility, safety and preliminary effectiveness of supervised exercise and outcome assessment delivered via telehealth for women recovering from gynaecological cancer.
UnitingCare Hospital: The Wesley Hospital
Collaborator: Dr Tom Bailey, The University of Queensland
Dr Daveson aims to better understand the relationship between gut microbes and the immune response to gluten that lead to changes in the clinical symptoms of coeliac disease.
UnitingCare Hospital: The Wesley Hospital
Collaborator: A/Prof Severine Navarro, QIMR
In conducting this study, A/Prof Wong hopes to provide proof-of-principle that FAPI PET/CT provides a clinically useful imaging modality for the staging/restaging of pancreatic cancer.
UnitingCare Hospital: The Wesley Hospital, St Andrew’s War Memorial Hospital, St Stephen’s Hospital, Buderim Hospital
Collaborator: Dr Sepinoud Firouzmand, i-MED
The project team aim to improve rehabilitation outcomes using a weightbearing monitoring sensor to record patient compliance with rehabilitation protocols and evaluate whether this is feasible for both patients and clinicians.
UnitingCare Hospital: The Wesley Hospital
Collaborator: Dr Panagiotis Barlas, Jamieson Trauma Institute – Metro North Health
This project aims to identify if gut microbiome diversity and richness influences immunotherapy response in patients with advanced melanoma.
UnitingCare Hospital: The Wesley Hospital, St Andrew’s War Memorial Hospital
Collaborator: A/Prof Jim Coward, Icon Cancer Centre
The AFTERCOR study aims to elucidate the long-term effects of COVID-19. In particular, AFTERCOR study will characterize renal, pulmonary, hepatic and neurological dysfunctions post COVID-19 and resulting health-related quality of life.
UnitingCare Hospital: The Wesley Hospital, St Andrew’s War Memorial Hospital
Collaborator: Prof John Fraser, St Andrew’s War Memorial Hospital
Dr Clark aims to investigate if using oral Tranexamic Acid reduces post-operative pain, swelling and bleeding associated with total knee arthroplasty.
UnitingCare Hospital: The Wesley Hospital, St Andrew’s War Memorial Hospital
Collaborator: Prof Robert Ware, Menzies Health Institute Queensland – Griffith University
In this multi-phase study, the research team will attempt to investigate the benefit of nasal high-flow during shared airway anaesthesia to improve outcomes such as unintended ICU admission or even cardiac arrest.
UnitingCare Hospital: St Andrew’s War Memorial Hospital, The Wesley Hospital
Collaborator: Prof John Fraser, St Andrew’s War Memorial Hospital
Motor Neuron Disease (MND) patients have increased levels of homocysteinsulfinic acid, an excitotoxin that can be produced by the gut microbiota.  In this follow-up study, Prof McCombe will investigate if increases in these excitotoxins change during disease progression and correlate with survival. These toxins could contribute to the onset of MND. It is possible that eliminating these gut toxins could lead to better patient outcomes.
UnitingCare Hospital: The Wesley Hospital, St Andrew’s War Memorial Hospital
Collaborator: Dr Aven Lee, The University of Queensland
Gastrointestinal pathology and changes in the gut microbiome are some of the earliest non-motor symptoms of Parkinson’s disease (PD) and often precede the onset of classic motor deficits like tremors. This research program will evaluate the gut microbiome changes in people with PD at high resolution to uncover new therapeutic targets and microbiome signatures with the aim of developing new treatments and biomarkers for earlier clinical diagnosis of PD.
This work will build on our ongoing clinical trial for restoration of the gut microbiome in PD which is funded by WMR and the Advance Queensland Program.   
UnitingCare Hospital: St Andrew’s War Memorial Hospital
Collaborator: Dr Richard Gordon, The University of Queensland
New research suggests that there may be long-term neurological consequences in those that survive COVID-19 infections, in particular brain damage.  Understanding the brain architecture and associated tissue pathologies will be key to gain insights into virally-driven presentation of COVID-19 in the brain and perhaps correlate back to clinical symptoms identified in the AFTERCOR study.
UnitingCare Hospital: St Andrew’s War Memorial Hospital, The Wesley Hospital
Collaborator: Dr Arutha Kulasinghe, The University of Queensland

Research is critical to advancing healthcare. Wesley Medical Research fosters a strong culture in UnitingCare Hospitals, improving health outcomes by linking medical research and clinical practice.

In the last 2 years, Wesley Medical Research has awarded over $5 million across a range of research fields and addressing a wide array of topics. Once again, congratulations to our recipients. We look forward to making an impact on the lives of sick and vulnerable people through the outcomes of these diverse research projects.

Contact

For further information, please contact Wesley Medical Research Head of Research Operations, Laura Pareezer at research@wesleyresearch.org.au.

More to explore...

Clinical nurse with patient, in consultation room.

Wesley Medical Research Annual Report – 2020-2021

For more than 26 years, Wesley Medical Research has continued to push the frontiers of medicine, delivering real impact to patients while contributing to knowledge through research worldwide. This year’s Annual Report shows updates and achievements from the start of July 2020 through to the end of June 2021.

Read More »

Wesley Medical Research

Scroll to Top